Clinical Trial Update: Effect of Magnesium Alginate in Infants With Gastroesophageal Reflux. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating magnesium alginate for gastroesophageal reflux in infants is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux

Snippet

Sponsor: Policlinico Hospital | Conditions: Gastro Esophageal Reflux | Phase 3 | Status: COMPLETED